Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Argentina Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20191
20201
20211
20223
20231
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Terminated5
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH3
Anthera Pharmaceuticals2
Eli Lilly and Company2
Alumis Inc1
Amgen1
Beeline Medicines Corporation1
Bristol-Myers Squibb1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Zura Bio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases14
Lupus Erythematosus, Systemic6
Immune System Diseases5
Arthritis, Rheumatoid3
Connective Tissue Diseases3
Dry Eye Syndromes2
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating2
Sjogren's Syndrome2
Arthritis1
Fatigue1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.